|
π¦
|
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
12 auth.
S. Nissen,
E. Tuzcu,
P. Schoenhagen,
B. G. Brown,
Peter Ganz,
Robert A Vogel,
...
T. Crowe,
Gail Howard,
Christopher J Cooper,
Bruce R Brodie,
C. Grines,
A. N. DeMaria
|
11 |
2004 |
11
π¦
|
|
π
|
American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.
33 auth.
G. Mintz,
S. Nissen,
W. Anderson,
S. Bailey,
R. Erbel,
Facc,
P. Fitzgerald,
F. Pinto,
K. Rosenfield,
R. Siegel,
Facc E Murat Tuzcu,
P. Yock,
J. Abrams,
E. Bates,
B. Brodie,
...
P. Douglas,
G. Gregoratos,
M. Hlatky,
J. Hochman,
C. Tracy,
David D. Waters,
W. Winters,
Mintz Gs,
Nissen Se,
Anderson Wd,
Bailey Sr,
Erbel R,
Fitzgerald Pj,
Pinto Fj,
Rosenfield K,
Siegel Rj,
Tuzcu Em,
Yock Pg
|
10 |
2001 |
10
π
|
|
π¬
|
Risk of cardiovascular events associated with selective COX-2 inhibitors.
D. Mukherjee,
S. Nissen,
E. Topol
|
10 |
2001 |
10
π¬
|
|
π¦
|
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.
14 auth.
S. Nissen,
T. Tsunoda,
E. Tuzcu,
P. Schoenhagen,
C. Cooper,
M. Yasin,
G. Eaton,
M. Lauer,
W. Sheldon,
C. Grines,
...
S. Halpern,
T. Crowe,
J. Blankenship,
R. Kerensky
|
10 |
2003 |
10
π¦
|
|
π’
|
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.
A. Lincoff,
K. Wolski,
S. Nicholls,
S. Nissen
|
10 |
2007 |
10
π’
|
|
π¬
|
Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis
A. Nair,
Barry D. Kuban,
E. Tuzcu,
P. Schoenhagen,
S. Nissen,
D. Vince
|
10 |
2002 |
10
π¬
|
|
π’
|
Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease.
E. Topol,
S. Nissen
|
10 |
1995 |
10
π’
|
|
π¦
|
Intravascular ultrasound: novel pathophysiological insights and current clinical applications.
S. Nissen,
P. Yock
|
9 |
2001 |
9
π¦
|
|
π¦
|
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.
15 auth.
S. Nissen,
S. Nicholls,
K. Wolski,
R. Nesto,
S. Kupfer,
Alfonso T. Perez,
H. Jure,
Robert de Larochellière,
C. Staniloae,
K. Mavromatis,
...
J. Saw,
Bo Hu,
A. Lincoff,
E. Tuzcu,
for the PERISCOPE Investigators
|
9 |
2008 |
9
π¦
|
|
π¦
|
Effect of torcetrapib on the progression of coronary atherosclerosis.
10 auth.
S. Nissen,
J. Tardif,
S. Nicholls,
J. Revkin,
C. Shear,
W. Duggan,
...
W. RuΕΌyΕΕo,
W. Bachinsky,
G. Lasala,
E. Tuzcu
|
9 |
2007 |
9
π¦
|
|
π’
|
Effect of two intensive statin regimens on progression of coronary disease.
11 auth.
Stephen J. Nicholls,
C. Ballantyne,
P. Barter,
M. John Chapman,
Raimund M. Erbel,
P. Libby,
...
J. Raichlen,
K. Uno,
Marilyn Borgman,
K. Wolski,
S. Nissen
|
9 |
2011 |
9
π’
|
|
π¬
|
Extent and direction of arterial remodeling in stable versus unstable coronary syndromes : an intravascular ultrasound study.
P. Schoenhagen,
K. Ziada,
S. Kapadia,
T. Crowe,
S. Nissen,
E. Tuzcu
|
9 |
2000 |
9
π¬
|
|
π¦
|
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
10 auth.
S. Nissen,
E. Tuzcu,
P. Schoenhagen,
T. Crowe,
W. Sasiela,
J. Tsai,
...
J. Orazem,
R. Magorien,
C. O'shaughnessy,
P. Ganz
|
9 |
2005 |
9
π¦
|
|
π¦
|
Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial
11 auth.
S. Nissen,
E. Tuzcu,
P. Libby,
P. Thompson,
M. Ghali,
D. Garza,
...
L. Berman,
Harry Shi,
Ethel Buebendorf,
E. Topol,
for the CAMELOT Investigators
|
9 |
2004 |
9
π¦
|
